Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

AGLE Aeglea BioTherapeutics Inc

12,01

0,00 (0,00%)

31 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

Aeglea BioTherapeutics (NASDAQ:AGLE)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Aeglea BioTherapeutics Charts.

Aeglea BioTherapeutics (NASDAQ:AGLE)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Aeglea BioTherapeutics Charts.

News Aeglea BioTherapeutics Inc

Form EFFECT - Notice of Effectiveness
Dienstag 30 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 25 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Donnerstag 25 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 25 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Montag 1 April 2024 (2 Monate vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Mittwoch 20 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 18 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 18 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Donnerstag 14 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 28 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 28 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Weitere Aeglea BioTherapeutics Inc News-Artikel

Macarthur Minerals

Bank of America

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen